BG31496A3 - Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid - Google Patents

Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Info

Publication number
BG31496A3
BG31496A3 BG042018A BG4201879A BG31496A3 BG 31496 A3 BG31496 A3 BG 31496A3 BG 042018 A BG042018 A BG 042018A BG 4201879 A BG4201879 A BG 4201879A BG 31496 A3 BG31496 A3 BG 31496A3
Authority
BG
Bulgaria
Prior art keywords
amino
alkyl
ortoanizamid
sulphonyl
obtaining
Prior art date
Application number
BG042018A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michel Thominer
Jacques Acher
Jean Monier
Original Assignee
Societe D'etudes Scientifiques Et Industriellesde L'ile-De-France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe D'etudes Scientifiques Et Industriellesde L'ile-De-France filed Critical Societe D'etudes Scientifiques Et Industriellesde L'ile-De-France
Publication of BG31496A3 publication Critical patent/BG31496A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG042018A 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid BG31496A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
BG31496A3 true BG31496A3 (en) 1982-01-15

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
BG043588A BG31497A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG042018A BG31496A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG043588A BG31497A3 (en) 1978-01-20 1979-01-10 Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid

Country Status (42)

Country Link
US (2) US4294828A (fr)
JP (1) JPS6049192B2 (fr)
AR (2) AR221354A1 (fr)
AT (1) AT377977B (fr)
AU (1) AU528561B2 (fr)
BE (1) BE872585A (fr)
BG (2) BG31497A3 (fr)
CA (1) CA1101430A (fr)
CH (1) CH637927A5 (fr)
CS (1) CS226181B2 (fr)
CY (1) CY1201A (fr)
DD (1) DD141520A5 (fr)
DE (1) DE2901181C2 (fr)
DK (1) DK158346C (fr)
EG (1) EG14045A (fr)
ES (2) ES476755A1 (fr)
FI (1) FI71126C (fr)
FR (1) FR2415099A1 (fr)
GB (2) GB2083458B (fr)
GR (1) GR64431B (fr)
HK (1) HK12184A (fr)
HU (1) HU179793B (fr)
IE (1) IE47798B1 (fr)
IL (1) IL56411A (fr)
IN (1) IN150226B (fr)
IT (1) IT1164655B (fr)
LU (1) LU80786A1 (fr)
MC (1) MC1232A1 (fr)
MX (2) MX5793E (fr)
NL (1) NL191707C (fr)
NO (1) NO151320C (fr)
NZ (1) NZ189378A (fr)
OA (1) OA06156A (fr)
PH (2) PH15725A (fr)
PL (2) PL116532B1 (fr)
PT (1) PT69068A (fr)
RO (2) RO76393A (fr)
SE (2) SE448874B (fr)
SU (1) SU820659A3 (fr)
YU (2) YU42172B (fr)
ZA (1) ZA79219B (fr)
ZM (1) ZM579A1 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
MXPA05012317A (es) * 2003-05-16 2006-01-30 Pfizer Prod Inc Combinaciones terapeuticas de agentes antipsicoticos atipicos con agentes moduladores del gaba anticonvulsivos o benzodiazepinas.
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
BRPI0510942A (pt) * 2004-05-11 2007-07-17 Pfizer Prod Inc combinação de antipsicóticos atìpicos e antagonistas do receptor 5-ht1b
CA2605447A1 (fr) * 2005-04-22 2006-11-02 Wyeth Nouvelles combinaisons therapeutiques pour le traitement ou la prevention de troubles psychotiques
EP2671508B1 (fr) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Système pharma-informatique
CA2663377A1 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap)
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
CA2727573A1 (fr) * 2008-06-25 2009-12-30 Pfizer Inc. Composes diaryle et leurs utilisations
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
BR112012031959A2 (pt) 2010-06-17 2015-09-22 Lupin Ltd um processo aperfeiçoado para preparação de amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
CN111233731B (zh) 2016-11-28 2021-05-14 Lb制药公司 精神药剂及其用途
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
WO2019113079A1 (fr) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Mélanges non racémiques et leurs utilisations
EP3720435B1 (fr) 2017-12-05 2024-03-06 Sunovion Pharmaceuticals Inc. Formes cristallines et leurs procédés de production
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
US11160758B2 (en) 2019-06-04 2021-11-02 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (fr) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
SE7900380L (sv) 1979-07-21
US4294828A (en) 1981-10-13
MX7623E (es) 1990-03-27
PH22287A (en) 1988-07-22
YU25483A (en) 1983-10-31
GB2083458B (en) 1983-03-09
IL56411A0 (en) 1979-03-12
AU528561B2 (en) 1983-05-05
MX5793E (es) 1984-07-19
PH15725A (en) 1983-03-18
FI790182A (fi) 1979-07-21
NL7900457A (nl) 1979-07-24
FR2415099A1 (fr) 1979-08-17
GB2012765B (en) 1982-09-08
YU5079A (en) 1983-06-30
CY1201A (en) 1983-12-31
ZA79219B (en) 1980-01-30
CA1101430A (fr) 1981-05-19
NZ189378A (en) 1983-03-15
US4401822A (en) 1983-08-30
JPS54145658A (en) 1979-11-14
IE47798B1 (en) 1984-06-27
CS226181B2 (en) 1984-03-19
NO151320C (no) 1985-04-17
JPS6049192B2 (ja) 1985-10-31
OA06156A (fr) 1981-06-30
EG14045A (en) 1983-09-30
LU80786A1 (fr) 1979-09-07
NL191707B (nl) 1995-12-01
ES477782A1 (es) 1979-09-16
PL118151B1 (en) 1981-09-30
RO76393A (fr) 1981-03-30
PT69068A (fr) 1979-02-01
DK20979A (da) 1979-07-21
YU42172B (en) 1988-06-30
ATA39879A (de) 1983-12-15
SE8603773D0 (sv) 1986-09-09
BG31497A3 (en) 1982-01-15
ES476755A1 (es) 1979-06-01
IE790092L (en) 1979-07-20
IT7947706A0 (it) 1979-01-18
FI71126C (fi) 1986-11-24
GB2012765A (en) 1979-08-01
HU179793B (en) 1982-12-28
SE460968B (sv) 1989-12-11
ZM579A1 (en) 1979-12-21
CH637927A5 (fr) 1983-08-31
AT377977B (de) 1985-05-28
DK158346B (da) 1990-05-07
DE2901181A1 (de) 1979-07-26
YU41278B (en) 1986-12-31
IT1164655B (it) 1987-04-15
NO790180L (no) 1979-07-23
NO151320B (no) 1984-12-10
IN150226B (fr) 1982-08-21
GB2083458A (en) 1982-03-24
RO80311A (fr) 1982-12-06
SU820659A3 (ru) 1981-04-07
FR2415099B1 (fr) 1981-02-20
NL191707C (nl) 1996-04-02
AU4337379A (en) 1979-07-26
BE872585A (fr) 1979-06-07
PL212899A1 (fr) 1980-01-14
DD141520A5 (de) 1980-05-07
SE448874B (sv) 1987-03-23
PL116532B1 (en) 1981-06-30
HK12184A (en) 1984-02-24
IL56411A (en) 1982-09-30
MC1232A1 (fr) 1979-10-26
AR220574A1 (es) 1980-11-14
DE2901181C2 (de) 1984-07-19
AR221354A1 (es) 1981-01-30
DK158346C (da) 1990-10-08
SE8603773L (sv) 1986-09-09
FI71126B (fi) 1986-08-14
GR64431B (en) 1980-03-21

Similar Documents

Publication Publication Date Title
BG31496A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31645A3 (en) Method for obtaining of phenetanolamine
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG31499A3 (en) Method for obtaining of 1- vinyl- triazol derivatives
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG34338A3 (en) Method for obtaining thiadiazolylcephalosporines
BG33294A3 (en) Method for obtaining the derivatives of 4- dezacetyl- vincaledcoblactine c- 3- carboxyhydrazid
BG37993A3 (en) Method for preparing 4- quinolonic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG31492A3 (en) Method for obtaining phenetanolamines
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG30021A3 (en) Method for obtaining of imidazoisohinolin- dion
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
BG28574A3 (en) Method of obtaining of 4- diphenylmethylene- 1- hydroxybensylpiperidin
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG32117A4 (en) Method for obtaining of oleandomicine
BG28415A4 (en) Method of obtaining of 9-hydroxyoctahydrobenzo (c) hynolines
BG37994A3 (en) Method for preparing tetrahydroquinolinic derivatives
BG33283A3 (en) Method for obtaining of pyridazinylhydrazon
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG31947A3 (en) Method for obtaining of acetidine derivatives
BG36347A3 (en) Method for preparing thienopyridinon derivatives